Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | Solactive ISS ESG Nordic Investable Universe Net Zero Pathway |
| Investeringsfocus | Aandelen, Europa, Sociaal/Milieu |
| Fondsgrootte | EUR 123 m |
| Totale kostenratio (TER) | 0,15% p.a. |
| Replicatie | Fysiek (Volledige replicatie) |
| Juridische structuur | ETF |
| Strategierisico | Langdurig |
| Duurzaamheid | Yes |
| Valuta van het fonds | EUR |
| Valutarisico | Valuta niet gedekt |
| Volatiliteit 1 jaar (in EUR) | 16,86% |
| Startdatum/Noteringsdatum | 12 april 2023 |
| Distributiebeleid | Accumulerend |
| Distributiefrequentie | - |
| Vestigingsplaats van het fonds | Ierland |
| Fondsaanbieder | Xtrackers |
| Fondsstructuur | Open-ended Investment Company (OEIC) |
| UCITS-conformiteit | Yes |
| Administrateur | State Street Custodial Services (Ireland) Limited |
| Beleggingsadviseur | DWS Investments UK Limited |
| Bewaarbank | State Street Custodial Services (Ireland) Limited, Dublin 2 |
| Revisiebedrijf | Pricewaterhouse Coopers |
| Einde belastingjaar | 31 december |
| Vertegenwoordiger van Zwitserland | DWS CH AG |
| Zwitserse uitbetalende instantie | Deutsche Bank (Suisse) SA |
| Duitsland | 30% belastingvermindering |
| Zwitserland | Geen ESTV-rapportage |
| Oostenrijk | Belastingrapportagefonds |
| UK | UK-rapportage |
| Indextype | - |
| Swap tegenpartij | - |
| Collateral manager | |
| Effectenlening | No |
| Tegenpartij die effecten uitleent |
| Novo Nordisk | 6,35% |
| Investor | 3,91% |
| Novonesis Novozymes | 3,13% |
| DSV A/S | 3,03% |
| Assa Abloy | 2,27% |
| Genmab | 2,26% |
| Zealand Pharma | 2,13% |
| Lifco | 2,09% |
| Danske Bank | 2,08% |
| Mycronic | 2,00% |
| Zweden | 48,04% |
| Denemarken | 25,91% |
| Finland | 7,21% |
| Noorwegen | 7,04% |
| Industrie | 20,97% |
| Financieel | 17,51% |
| Gezondheidszorg | 16,31% |
| Vastgoed | 10,73% |
| Anders | 34,48% |
| YTD | -2,22% |
| 1 maand | -4,35% |
| 3 maanden | +2,95% |
| 6 maanden | -0,70% |
| 1 jaar | -7,84% |
| 3 jaar | - |
| 5 jaar | - |
| Since inception | +11,31% |
| 2025 | +0,82% |
| 2024 | +4,00% |
| 2023 | - |
| 2022 | - |
| Volatiliteit 1 jaar | 16,86% |
| Volatiliteit 3 jaar | - |
| Volatiliteit 5 jaar | - |
| Rendement/Risico 1 jaar | -0,32 |
| Rendement/Risico 3 jaar | - |
| Rendement/Risico 5 jaar | - |
| Maximaal waardedaling 1 jaar | -20,93% |
| Maximaal waardedaling 3 jaar | - |
| Maximaal waardedaling 5 jaar | - |
| Maximaal waardedaling sinds aanvang | -23,88% |
| Beursnotering | Handelsvaluta | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | XNZN | - - | - - | - |
| London Stock Exchange | GBP | XNZN | XNZN LN XNZNEUIV | XNZN.L I2S2INAV.DE | |
| XETRA | EUR | XNZN | XNZN GR XNZNGBIV | XNZN.DE I2S4INAV.DE |
| Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
|---|---|---|---|---|
| UBS MSCI EMU Socially Responsible UCITS ETF EUR dis | 828 | 0.20% p.a. | Distributing | Full replication |
| Amundi MSCI EMU ESG Broad Transition UCITS ETF Dist | 127 | 0.12% p.a. | Distributing | Full replication |
| HSBC Europe Ex UK Screened Equity UCITS ETF EUR (Dist) | 34 | 0.15% p.a. | Distributing | Full replication |